| Model Number |
RMT311417 |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Codes |
Aneurysm (1708); No Code Available (3191)
|
| Date of Event |
02/19/2018
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), users are made aware of the risks associated with type ii endoleaks and are instructed to consider the risks and benefits discussed in the ifu for each patient before using the devices.Additionally, per ifu, adverse events that may occur and / or require intervention include, but are not limited to endoleak and aneurysm enlargement. .
|
| |
|
Event or Problem Description
|
|
It was reported that on (b)(6) 2011, the patient presented with a 55 mm abdominal aortic aneurysm that was treated with gore® excluder® aaa endoprostheses.Follow-up imaging showed that the aneurysm size appeared to be stable until (b)(6) 2017 (52 mm).Aneurysm growth to 60 mm was visible on (b)(6) 2018.Continuous aneurysm growth to 65 mm was identified on (b)(6) 2019.On (b)(6) 2019, a type ii endoleak of unspecified origin was identified and successfully treated with embolization on (b)(6) 2019.The patient tolerated the procedure.
|
| |
|
Search Alerts/Recalls
|